Literature DB >> 22615050

DOTAGA-anhydride: a valuable building block for the preparation of DOTA-like chelating agents.

Claire Bernhard1, Mathieu Moreau, Damien Lhenry, Christine Goze, Frédéric Boschetti, Yoann Rousselin, François Brunotte, Franck Denat.   

Abstract

A DOTA derivative that contains an anhydride group was readily synthesized by reacting DOTAGA with acetic anhydride and its reactivity was investigated. Opening the anhydride with propylamine led to the selective formation of one of two possible regioisomers. The structure of the obtained isomer was unambiguously determined by 1D and 2D NMR experiments, including COSY, HMBC, and NOESY techniques. This bifunctional chelating agent offers a convenient and attractive approach for labeling biomolecules and, more generally, for the synthesis of a large range of DOTA derivatives. The scope of the reaction was extended to prepare DOTA-like compounds that contained various functional groups, such as isothiocyanate, thiol, ester, and amino acid moieties. This versatile building block was also used for the synthesis of a bimodal tag for SPECT or PET/optical imaging.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22615050     DOI: 10.1002/chem.201200132

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  10 in total

1.  Development of a multi faceted platform containing a tetrazine, fluorophore and chelator: synthesis, characterization, radiolabeling, and immuno-SPECT imaging.

Authors:  Anthony W McDonagh; Brooke L McNeil; Julie Rousseau; Ryan J Roberts; Helen Merkens; Hua Yang; François Bénard; Caterina F Ramogida
Journal:  EJNMMI Radiopharm Chem       Date:  2022-06-06

2.  Associating a negatively charged GdDOTA-derivative to the Pittsburgh compound B for targeting Aβ amyloid aggregates.

Authors:  André F Martins; Alexandre C Oliveira; Jean-François Morfin; Douglas V Laurents; Éva Tóth; Carlos F G C Geraldes
Journal:  J Biol Inorg Chem       Date:  2015-11-27       Impact factor: 3.358

3.  Synthesis and preclinical evaluation of DOTAGA-conjugated PSMA ligands for functional imaging and endoradiotherapy of prostate cancer.

Authors:  Martina Weineisen; Jakub Simecek; Margret Schottelius; Markus Schwaiger; Hans-Jürgen Wester
Journal:  EJNMMI Res       Date:  2014-11-25       Impact factor: 3.138

4.  iEDDA Conjugation Reaction in Radiometal Labeling of Peptides with 68Ga and 64Cu: Unexpected Findings.

Authors:  Shanna Litau; Uwe Seibold; Björn Wängler; Ralf Schirrmacher; Carmen Wängler
Journal:  ACS Omega       Date:  2018-10-25

5.  Feasibility study and direct extraction of endogenous free metallic cations combining hemodialysis and chelating polymer.

Authors:  Marco Natuzzi; Coralie Grange; Thomas Gréa; Thomas Brichart; Axel Aigle; Denise Bechet; Benoit Hautefeuille; Eloise Thomas; Jean-Yves Ayoub; Jeanne-Marie Bonnet; Vanessa Louzier; Bernard Allaouchiche; Aymeric Couturier; Alexandra Montembault; Paula Nunes de Oliveira; Laurent David; François Lux; Olivier Tillement
Journal:  Sci Rep       Date:  2021-10-07       Impact factor: 4.379

6.  [(111)In]PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgery.

Authors:  Margret Schottelius; Martina Wirtz; Matthias Eiber; Tobias Maurer; Hans-Jürgen Wester
Journal:  EJNMMI Res       Date:  2015-11-25       Impact factor: 3.138

Review 7.  Bimodal imaging probes for combined PET and OI: recent developments and future directions for hybrid agent development.

Authors:  Uwe Seibold; Björn Wängler; Ralf Schirrmacher; Carmen Wängler
Journal:  Biomed Res Int       Date:  2014-04-16       Impact factor: 3.411

8.  Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment.

Authors:  Géraldine Le Duc; Stéphane Roux; Amandine Paruta-Tuarez; Sandrine Dufort; Elke Brauer; Arthur Marais; Charles Truillet; Lucie Sancey; Pascal Perriat; François Lux; Olivier Tillement
Journal:  Cancer Nanotechnol       Date:  2014-07-01

Review 9.  89Zr-Immuno-Positron Emission Tomography in Oncology: State-of-the-Art 89Zr Radiochemistry.

Authors:  Sandra Heskamp; René Raavé; Otto Boerman; Mark Rijpkema; Victor Goncalves; Franck Denat
Journal:  Bioconjug Chem       Date:  2017-08-24       Impact factor: 4.774

10.  Radiolabeled F(ab')2-cetuximab for theranostic purposes in colorectal and skin tumor-bearing mice models.

Authors:  P-S Bellaye; M Moreau; O Raguin; A Oudot; C Bernhard; J-M Vrigneaud; L Dumont; D Vandroux; F Denat; A Cochet; F Brunotte; B Collin
Journal:  Clin Transl Oncol       Date:  2018-05-17       Impact factor: 3.405

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.